Literature DB >> 31967304

The early luteal hormonal profile in IVF patients triggered with hCG.

Lan N Vuong1,2,3, Tuong M Ho2,3, Toan D Pham2,3, Vu N A Ho2,3, Claus Yding Andersen4, Peter Humaidan5,6,7.   

Abstract

STUDY QUESTION: What is the early luteal phase hormonal profile in patients undergoing ovarian stimulation for IVF/ICSI followed by hCG trigger and a freeze-all strategy without luteal phase support? SUMMARY ANSWER: The peak concentration of progesterone occurred 4 days after oocyte pick-up (OPU + 4), with an average 35% fall from OPU + 4 to OPU + 6, and progesterone levels before and 12 h after hCG administration predicted levels during the early luteal phase. WHAT IS KNOWN ALREADY: The luteal phase during IVF differs from that during normal cycles, particularly with respect to the serum progesterone level profile. This can cause asynchrony between the embryo and the endometrium, potentially resulting in implantation failure and poor reproductive outcomes. STUDY DESIGN, SIZE, DURATION: This prospective study included 161 women with normal ovarian reserve receiving GnRH antagonist co-treatment during ovarian stimulation with FSH who were followed up to 6 days after OPU in a single IVF cycle. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Women aged 18-42 years undergoing IVF with ovarian stimulation using FSH were included. Ovulation was triggered with recombinant hCG 250 μg. Hormone levels were determined from blood samples taken on the day of trigger, before hCG, at 12, 24 and 36 h after hCG and at 1, 2, 3, 4, 5 and 6 days after OPU. The primary endpoint was early luteal phase serum concentrations of progesterone, LH, estradiol and hCG. MAIN RESULTS AND THE ROLE OF CHANCE: One outlier with a pre-hCG serum progesterone level of 11.42 ng/mL was excluded, so all analyses included 160 subjects. Progesterone levels began to increase 1 day after OPU, peaked 4 days after OPU (114 ng/mL), then declined from OPU + 5 onwards. Peak progesterone levels were at OPU + 4, OPU + 5 or OPU + 6 in 38.8, 29.4 and 13.8% of patients, respectively. Approximately two-thirds of patients had a fall in serum progesterone from OPU + 4 to OPU + 6. Pre-hCG progesterone levels correlated significantly with those at 24 h after hCG (r2 = 0.28; P < 0.001), which in turn correlated significantly with progesterone at OPU + 4 (r2 = 0.32; P < 0.001). LH peaked (4.4 IU/L) 12 h after hCG trigger, persisting for 24 h but was barely elevated compared with physiological levels. Serum estradiol peaked twice: at 24 h post-trigger and at OPU + 4. Highest hCG levels (130 mIU/mL) occurred at 24 h post-injection. The best correlations between the number of follicles ≥11 mm and serum progesterone level were seen at 24 and 36 h after hCG and OPU + 1. LIMITATIONS, REASONS FOR CAUTION: The influence of different profiles of serum progesterone on reproductive outcomes could not be determined because a freeze-all strategy was used in all patients. In addition, data were not available to relate serum hormone level findings with endometrial histology or endometrial receptivity analysis to clearly identify the relationship between serum hormones and the window of implantation. WIDER IMPLICATIONS OF THE
FINDINGS: Detailed information about early luteal phase hormone levels could be used to optimize and individualize luteal phase support to improve reproductive outcomes. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by My Duc Hospital, Ho Chi Minh City, Vietnam. All authors state that they have no conflicts of interest to disclose. TRIAL REGISTRATION NUMBER: NCT02798146; NCT03174691.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Entities:  

Keywords:  zzm321990 in vitro fertilization; hormones; human chorionic gonadotropin; luteal phase; luteinizing hormone; progesterone

Mesh:

Substances:

Year:  2020        PMID: 31967304     DOI: 10.1093/humrep/dez235

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  The Impact of Controlled Ovarian Stimulation on Serum Oxidative Stress Markers in Infertile Women with Endometriosis Undergoing ICSI.

Authors:  Michele Gomes Da Broi; Elisa Melo Ferreira; Aline Zyman Andrade; Alceu Afonso Jordão; Rui Alberto Ferriani; Paula Andrea Navarro
Journal:  Antioxidants (Basel)       Date:  2022-06-14

2.  Evolution of serum progesterone levels in the very early luteal phase of stimulated IVF/ICSI cycles post hCG trigger: a proof of concept study.

Authors:  Carol Coughlan; R Vitorino; L Melado; S Digma; J Sibal; R Patel; B Lawrenz; H Fatemi
Journal:  J Assist Reprod Genet       Date:  2022-04-07       Impact factor: 3.357

3.  Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?

Authors:  Imane Lalami; Julie Labrosse; Isabelle Cedrin-Durnerin; Marjorie Comtet; Claire Vinolas; Fabien Krief; Christophe Sifer; Maeliss Peigne; Michael Grynberg
Journal:  Reprod Biol Endocrinol       Date:  2022-06-11       Impact factor: 4.982

4.  The impact of preovulatory versus midluteal serum progesterone level on live birth rates during fresh embryo transfer.

Authors:  Abdelhamid Benmachiche; Sebti Benbouhedja; Abdelali Zoghmar; Peter Samir Hesjaer Al Humaidan
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

5.  The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study.

Authors:  Ying Zhang; Wenxian Zhao; Yifan Han; Xin Chen; Shaoyuan Xu; Yueyue Hu; Honglu Diao; Changjun Zhang
Journal:  Reprod Biol Endocrinol       Date:  2022-09-19       Impact factor: 4.982

6.  Determinants of the hCG Concentration in the Early Luteal Phase After Final Maturation of Follicles With Bolus Trigger of Recombinant hCG.

Authors:  Lan N Vuong; Toan D Pham; Vu N A Ho; Tuong M Ho; Peter Humaidan; Claus Yding Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-19       Impact factor: 5.555

7.  Endocrine Requirements for Oocyte Maturation Following hCG, GnRH Agonist, and Kisspeptin During IVF Treatment.

Authors:  Ali Abbara; Tia Hunjan; Vu N A Ho; Sophie A Clarke; Alexander N Comninos; Chioma Izzi-Engbeaya; Tuong M Ho; Geoffrey H Trew; Artsiom Hramyka; Tom Kelsey; Rehan Salim; Peter Humaidan; Lan N Vuong; Waljit S Dhillo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-06       Impact factor: 5.555

8.  Serum Progesterone Profile Across the Mid and Late Luteal Phase in Artificial Cycles Is Associated With Pregnancy Outcome.

Authors:  Elena Labarta; Cristina Rodríguez-Varela; Giulia Mariani; Ernesto Bosch
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.